文摘
We measured serum levels of anti-Gal(α1 → 3)Gal and anti-Gal(α1 → 2)Gal antibodies in 89 and 91 women, respectively, by using ELISA. These patients had cervical intraepithelial neoplasia (CIN) grades 1 to 3 and early invasive cervical carcinoma (ICC). Our objective was to compare anti-α-galactosyl antibody levels among them and with those of normal controls. High levels of anti-Gal(α1 → 2)Gal antibodies were detected in 22 % of patients (P